Back to Sphera Funds Management Ltd.

Sphera Funds Management Ltd.

All holdings · as of Dec 31, 2025

94 positions

CompanyClassValueShares% of portfolio
TEVA PHARMACEUTICAL INDUSTRIES LTDTEVAADR$35.07M1,123,5257.3%
BIOGEN INC.$16.67M94,7383.5%
MINERALYS THERAPEUTICS INCMLYSCommon Stock$16.29M449,0033.4%
Syndax Pharmaceuticals Inc$16.02M762,5633.3%
NOVA LTD$15.71M47,8463.3%
TOWER SEMICONDUCTOR LTD$14.39M122,5133.0%
Cogent Biosciences, Inc.$13.44M378,5002.8%
ASTRAZENECA PLC$12.42M135,0602.6%
SANOFI$11.61M239,5152.4%
ELI LILLY & Co$9.72M9,0402.0%
AMICUS THERAPEUTICS INC$9.38M658,3772.0%
IMMATICS N.V$9.04M861,1051.9%
BioMarin Pharmaceutical Inc$8.74M147,0001.8%
BridgeBio Pharma, Inc.$8.24M107,7461.7%
Oric Pharmaceuticals, Inc.$8.22M1,004,3781.7%
Dyne Therapeutics, Inc.$7.69M392,8941.6%
Trevi Therapeutics, Inc.$7.49M598,5341.6%
JOHNSON & JOHNSON$7.42M35,8311.5%
Savara IncSVRACommon Stock$7.10M1,178,1641.5%
Scholar Rock Holding Corp$6.97M158,2651.5%
WAVE LIFE SCIENCES LTD$6.94M408,1661.5%
Ultragenyx Pharmaceutical Inc.$6.91M300,6231.4%
Cybin Inc.$6.75M825,5761.4%
Annexon, Inc.$6.61M1,316,2121.4%
BIOCRYST PHARMACEUTICALS INC$6.54M837,8891.4%
Celldex Therapeutics, Inc.$6.51M239,7641.4%
SOLENO THERAPEUTICS, INC.$6.31M136,3141.3%
Apellis Pharmaceuticals, Inc.$6.30M250,9611.3%
GSK PLC$5.98M122,0001.3%
Enphase Energy, Inc.$5.98M186,5001.2%
NOVO-NORDISK A S$5.89M115,6771.2%
Cytokinetics Inc$5.83M91,7171.2%
AbbVie Inc.$5.77M25,2561.2%
SOLAREDGE TECHNOLOGIES, INC.$5.67M196,5361.2%
ACADIA Pharmaceuticals Inc$5.67M212,2021.2%
Vor Biopharma Inc.$5.37M410,4171.1%
Merck & Co., Inc.$5.12M48,6001.1%
NOVARTIS AG$5.10M37,0001.1%
Forte Biosciences, Inc.$5.07M185,8691.1%
Kodiak Sciences Inc.KODCommon Stock$4.91M175,5001.0%
Tango Therapeutics, Inc.$4.82M544,5631.0%
SOLAREDGE TECHNOLOGIES INC$4.70M4,000,0001.0%
ASTRIA THERAPEUTICS INC$4.66M355,7251.0%
MEDIWOUND LTD$4.25M230,3470.9%
CAMTEK LTD.$4.20M39,4980.9%
Revolution Medicines, Inc.$4.18M52,5000.9%
ADVANCED MICRO DEVICES INC$3.86M18,0400.8%
Climb Bio, Inc.CLYMCommon Stock$3.73M932,2470.8%
Alpha Cognition Inc.$3.69M567,6160.8%
Enliven Therapeutics, Inc.ELVNCommon Stock$3.49M226,7650.7%
← PrevPage 1 of 2Next →